Adjuvants for human vaccines--current status, problems and future prospects

Vaccine
R K Gupta, G R Siber

Abstract

Adjuvants help antigen to elicit an early, high and long-lasting immune response with less antigen, thus saving on vaccine production costs. In recent years, adjuvants received much attention because of the development of purified, subunit and synthetic vaccines which are poor immunogens and require adjuvants to evoke the immune response. With the use of adjuvants immune response can be selectively modulated to major histocompatibility complex (MHC) class I or MHC class II and Th1 or Th2 type, which is very important for protection against diseases caused by intracellular pathogens such as viruses, parasites and bacteria (Mycobacterium). A number of problems are encountered in the development and use of adjuvants for human vaccines. The biggest issue with the use of adjuvants for human vaccines, particularly routine childhood vaccines, is the toxicity and adverse side-effects of most of the adjuvant formulations. At present the choice of adjuvants for human vaccination reflects a compromise between a requirement for adjuvanticity and an acceptable low level of side-effects. Other problems with the development of adjuvants include restricted adjuvanticity of certain formulations to a few antigens, use of aluminum adjuvants as re...Continue Reading

References

Jul 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·L ChedidE Lederer
Feb 1, 1992·Research in Immunology·N van Rooijen
Feb 1, 1992·Research in Immunology·C R AlvingN M Wassef
Jan 1, 1992·Vaccine·A W Heath, J H Playfair
Jun 24, 1991·Journal of Immunological Methods·C R Alving
Aug 1, 1991·Current Opinion in Cell Biology·J J NeefjesH L Ploegh
Mar 1, 1991·Molecular Immunology·J H EldridgeR M Gilley
Jan 1, 1990·International Reviews of Immunology·R Edelman, C O Tacket
May 1, 1990·The Journal of Infectious Diseases·J B Robbins, R Schneerson
Sep 28, 1990·Science·R Langer
Jan 1, 1986·Annual Review of Immunology·H S WarrenL A Chedid
Mar 1, 1988·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·O Majgaard Jensen, C Koch
Jan 1, 1987·The Journal of Experimental Medicine·J P CoutelierJ Van Snick
Nov 1, 1985·Annales De L'Institut Pasteur. Immunology·L Chedid
Aug 19, 1974·Biochemical and Biophysical Research Communications·F EllouzE Lederer
Jan 1, 1981·Pharmacology & Therapeutics·O LüderitzE T Rietschel
Jan 1, 1984·Journal of Biological Standardization·J Lyng, G Nyerges
May 1, 1980·Reviews of Infectious Diseases·R Edelman
Apr 12, 1995·Journal of Immunological Methods·R K Gupta, G R Siber
Sep 1, 1994·International Journal of Immunopharmacology·J W Hadden
Sep 1, 1994·Biologicals : Journal of the International Association of Biological Standardization·R K Gupta, G R Siber
May 1, 1993·Trends in Pharmacological Sciences·F M Audibert, L D Lise
Jul 1, 1993·Immunobiology·A Fortin, H M Thérien
Aug 12, 1993·Annals of the New York Academy of Sciences·C R AlvingG A Eddy
Jan 1, 1993·Vaccine·R K GuptaC K Gupta
Aug 6, 2003·Expert Review of Vaccines·Gregory Glenn
Jun 1, 1964·Proceedings of the Society for Experimental Biology and Medicine·A F WOODHOURM R HILLEMAN

❮ Previous
Next ❯

Citations

Aug 17, 2000·Springer Seminars in Immunopathology·A A HornerE Raz
Dec 21, 2006·Pharmaceutical Research·Jigna D PatelRussell J Mumper
Oct 4, 2011·Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology·Upma BagaiVineet Kumar
May 14, 2003·Journal of Colloid and Interface Science·Shan Li WangStanley L Hem
Dec 31, 1997·Lancet·S L Katz
Sep 21, 2000·Immunology Letters·B A Tjoa, G P Murphy
May 29, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·J KazzazD T O'Hagan
Oct 6, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·N PuriP J Sinko
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·H TakahataS S Davis
Aug 23, 2001·Advanced Drug Delivery Reviews·H O AlparS Somavarapu
Aug 23, 2001·Advanced Drug Delivery Reviews·I Jabbal-GillL Illum
Nov 24, 2001·Advanced Drug Delivery Reviews·I M van der LubbenH E Junginger
Jun 6, 2000·Advanced Drug Delivery Reviews·R K Gupta
Oct 17, 2006·Parasitology Today·H D Engers, T Godal
Mar 21, 2001·Vaccine·S ThoelenN Tornieporth
Apr 20, 2001·Vaccine·J S MoynihanC R Howard
Apr 3, 2001·Vaccine·D ChenL G Payne
Sep 26, 2002·Vaccine·Beata Halassy SpoljarJelka Tomasić

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.